Showing results (591-600 of 694) with videos related to

Sort By:
Pageof 70
BMC Health Services Research|July 18, 2018
Evaluating the implementation related challenges of Shasthyo Suroksha Karmasuchi (health protection scheme) of the government of Bangladesh: a study protocolSayem Ahmed, Md Zahid Hasan, Mohammad Wahid Ahmed, et al.
Open Forum Infectious Diseases|December 20, 2017
Fatal Puumala Hantavirus Disease: Involvement of Complement Activation and Vascular Leakage in the PathobiologyTarja Sironen, Jussi Sane, Marja-Liisa Lokki, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 3, 2020
Preclinical Pharmacology of [2-(3-Fluoro-5-Methanesulfonyl-phenoxy)Ethyl](Propyl)amine (IRL790), a Novel Dopamine Transmission Modulator for the Treatment of Motor and Psychiatric Complications in Parkinson DiseaseSusanna Waters, Clas Sonesson, Peder Svensson, et al.
Plos Neglected Tropical Diseases|February 22, 2020
High risk for human exposure to Rift Valley fever virus in communities living along livestock movement routes: A cross-sectional survey in KenyaCaroline Tigoi, Rosemary Sang, Edith Chepkorir, et al.
Translational Psychiatry|August 30, 2018
Association between amygdala neurokinin-1 receptor availability and anxiety-related personality traitsJohanna M Hoppe, Andreas Frick, Fredrik Åhs, et al.
The Lancet. Neurology|July 12, 2011
Simvastatin as add-on therapy to interferon β-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trialPer Soelberg Sorensen, Jan Lycke, Juha-Pekka Erälinna, et al.
CNS Neuroscience & Therapeutics|April 22, 2010
Altered processing of contextual information during fear extinction in PTSD: an fMRI studyAnsgar Rougemont-Bücking, Clas Linnman, Thomas A Zeffiro, et al.
Virology|April 25, 2000
Passive infusion of immune serum into simian immunodeficiency virus-infected rhesus macaques undergoing a rapid disease course has minimal effect on plasma viremiaJ M Binley, B Clas, A Gettie, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 22, 2020
A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease DementiaPer Svenningsson, Per Odin, Nil Dizdar, et al.
Journal of Infection and Public Health|October 14, 2025
Post COVID-19 condition phenotypes: A prospective cohort study identifying four symptom clusters and their impact on long-term outcomesTove Grafström, Guilherme W F Barros, Ida-Lisa Persson, et al.
Pageof 70